Skip to main content
. 2013 May 1;10:53. doi: 10.1186/1742-2094-10-53

Table 1.

Clinical and demographic features of TLE(HS) patients

Patients Gender Age (years) Side of HS Duration (years) Last seizure (days before surgery) TLE form AED during surgery
TLE 01
F
34.6
L
28.6
nd
Familial
PHT
TLE 02
F
29.1
L
22.1
2
Sporadic
CBZ
TLE 03
F
23.8
R
22.3
7
Sporadic
CBZ
TLE 04
M
42.8
R
41.2
3
Sporadic
CBZ
TLE 05
M
41.2
L
34.2
5
Sporadic
CBZ
TLE 06
M
50.8
R
48.8
7
Sporadic
CBZ
TLE 07
M
12.7
L
9.7
3
Sporadic
CBZ, PHT
TLE 08
F
43.8
B(L)a
41.8
nd
Sporadic
CBZ, LTG
TLE 09
F
58.2
R
57.7
nd
Sporadic
OXC, VPA
TLE 10
F
54.9
L
50.9
nd
Sporadic
CBZ
TLE 11
F
32.1
L
31.6
nd
Familial
CBZ
TLE 12
F
38.3
L
37.0
2
Familial
OXC
TLE 13
F
54.1
L
53.3
nd
Sporadic
OXC, PHT
TLE 14 M 34.4 R 34.2 nd Familial OXC

aThe hippocampal side was more affected when bilateral. When the patient’s last seizure was ‘nd’, the seizure most likely occurred over 7 days prior to surgery. TLE(HS), temporal lobe epilepsy associated with hippocampal sclerosis; M, male; F, female; B, bilateral; R, right; L, left; nd, not determined; AED, antiepileptic drug; CBZ, carbamazepine; PHT, phenytoin; OXC, oxcarbazepine; LTG, lamotrigine; VPA, valproate.